16 Feb 2017

Teva CEO steps down; FDA Warning Letters to firms in Japan, India & China

This week, Phispers highlights more bad news for Israeli drugmaker Teva, along with news on the ‘overwhelming efficacy’ of blood thinner Rivaroxaban over Aspirin, Sanofi’s plans to resubmit its application for Sa...

Radio Compass

PharmaCompass.com

Teva CEO steps down; FDA Warning Letters to firms in Japan, India & China

15 Feb 2017

Will a Spanish drug, retailing for under 10 euros, get sold in the U.S. for $89,000/year?

On February 9, 2017 Marathon Pharmaceuticals LLC received FDA approval for Emflaza (deflazacort), tablets and oral suspension, to treat patients aged 5 years and older with Duchenne muscular dystrophy (DMD), a rare genetic disorde...

Radio Compass

PharmaCompass.com

Will a Spanish drug, retailing for under 10 euros, get sold in the U.S. for $89,000/year?

09 Feb 2017

FDA’s 2016 Approvals of New Drugs, Formulations, Strengths & More

After 2 years of sky-high approval numbers, the US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research approved 22 novel drugs in 2016, down from the 19-year high of 45 in 2015. The FDA also approved...

Radio Compass

PharmaCompass.com

FDA’s 2016 Approvals of New Drugs, Formulations, Strengths & More
Copyright © 2017 LePro PharmaCompass OPC Private Limited, All rights reserved.